- FoI Number
- 2022-728
- Subject
- Migraine
- Date Received
- 09/02/2023
- Request and Response
-
1. How many patients have been treated with the following drugs in the past 4 months:
- Erenumab (Aimovig) - any disease 5
- Eptinezumab (Vyepti) - any disease 0
- Fremanezumab (Ajovy) - any disease 0
- Galcanezumab (Emgality) - any disease 0
- Botulinum Toxin (i.e., Botox, Dysport, Xeomin) - migraine ONLY
NHS Shetland uses Xeomin but cannot identify who has it ONLY for Migraine
2. How many patients have you treated in the last 4 months for chronic migraine (15+ headache days per month) and episodic migraine (4-15 headache days per month) with the following drugs:
Drugs
Chronic Migraine (15+ headache days per month)
Episodic Migraine (4-15 headache days per month)
Erenumab
Eptinezumab
Fremanezumab
Galcanezumab
Botulinum Toxin
In accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested. NHS Shetland does not collect this data.